“Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS”. 2025. Mediterranean Journal of Hematology and Infectious Diseases 17 (1): e2025025. https://doi.org/10.4084/MJHID.2025.025.